Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2026-01-13 @ 11:34 AM
Study NCT ID:
NCT04562558
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-11
First Post:
2020-09-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia
Sponsor:
xiang yang
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gestational Trophoblastic Tumor | View |
| None | Gestational Trophoblastic Neoplasia | View |
| None | Stage I Gestational Trophoblastic Tumor | View |
| None | Stage II Gestational Trophoblastic Tumor | View |
| None | Stage III Gestational Trophoblastic Tumor | View |
| None | Invasive Mole | View |
| None | Choriocarcinoma | View |